Newest studies
Every summary in our library, newest first, as a dated timeline.
Showing 4,126–4,150 of 27,380 studies, newest first · page 166 of 1096.
June 2025 25
-
2025-06-01
Current advances and unmet needs in Alzheimer's disease trials for individuals with Down syndrome: Navigating new therapeutic frontiers
55/100 ✓ Peer-reviewed Disease mechanisms Alzheimer s & Dementia
Key finding: HIGHLIGHTS: Despite recent progress in Alzheimer's disease (AD) treatments for the general population-particularly monoclonal anti-amyloid therapies such as lecanemab and donanemab-individuals with Down syndrome (DS) were excluded from pivotal trials, leaving significant gaps in knowledge regarding safety and efficacy.
Full summary, score breakdown and related studies → Original source
-
2025-06-01
Multitarget Compounds Designed for Alzheimer, Parkinson, and Huntington Neurodegeneration Diseases
42/100 ✓ Peer-reviewed Inflammation and the immune system Pharmaceuticals
Key finding: The complexity of the above pathologies has clearly demonstrated that such single-target drugs are inadequate to achieve a successful therapeutic result.
Full summary, score breakdown and related studies → Original source
-
2025-06-01
Severity and Prognosis of Vascular Dementia in Patients with Acute Cerebral Infarction Combined with H-Type Hypertension and Its Correlation with Uric Acid Levels
39/100 ✓ Peer-reviewed Cognitive tests and assessment Neuropsychiatric Disease and Treatment
Key finding: The observation group had significantly higher blood uric acid levels than the control group (P<0.05). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-01
Extension and external validation of mapping between the Mini‐Mental State Examination and the Clinical Dementia Rating scale in patients with Alzheimer's disease
41/100 ✓ Peer-reviewed Cognitive tests and assessment Alzheimer s & Dementia
Key finding: demonstrated high goodness of fit and satisfied all validation metrics. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-01
Blood Uric Acid in Mild Cognitive Impairment: A Cross-Sectional Study of Older Chinese Adults
42/100 ✓ Peer-reviewed Mild cognitive impairment Neuropsychiatric Disease and Treatment
Key finding: A total of 90 (38.96%) participants were healthy and 141 (61.04%) had MCI. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-01
Inequalities in Mild Cognitive Impairment Risk Among Chinese Middle-Aged and Older Adults: Insights from an Integrated Learning Model
44/100 ✓ Peer-reviewed Mild cognitive impairment Risk Management and Healthcare Policy
Key finding: The CNN-BiLSTM-Attention model demonstrated relatively promising predictive performance (AUC: 0.7317), with moderately high sensitivity (0.6902) and a high negative predictive value (NPV) of 0.9414. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-01
Comparing clinical features of behavioral variant frontotemporal dementia and Alzheimer's disease using network analysis
39/100 ✓ Peer-reviewed Lewy body dementia Alzheimer s & Dementia
Key finding: Both networks were densely connected, reflecting comorbidity between neuropsychiatric symptoms and cognitive scores. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-01
A hypothesis explaining Alzheimer's disease, Parkinson's disease, and dementia with Lewy bodies overlap
43/100 ✓ Peer-reviewed Lewy body dementia Alzheimer s & Dementia
Key finding: Lewy body-involving diseases (LBD) are commonly associated with Parkinson's disease (PD) featuring voluntary movement inhibition, due to dopaminergic neuron dysfunction in the substantia nigra.
Full summary, score breakdown and related studies → Original source
-
2025-06-01
TDP-43 dysregulation of polyadenylation site selection is a defining feature of RNA misprocessing in amyotrophic lateral sclerosis and frontotemporal dementia
51/100 ✓ Peer-reviewed Lewy body dementia Journal of Clinical Investigation
Key finding: Our findings define changes in polyadenylation site selection as a previously understudied feature of TDP-43-driven disease pathology in ALS/FTD and highlight a potentially important mechanistic link between TDP-43 dysfunction and tau regulation.
Full summary, score breakdown and related studies → Original source
-
2025-06-01
A lifespan perspective on cognitive reserve and risk for dementia
47/100 ✓ Peer-reviewed Risk factors Alzheimer s & Dementia
Key finding: Higher GCA was associated with lower dementia risk (hazard ratio = 0.865, 95% confidence interval = 0.756 to 0.990). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-01
Leveraging Artificial Intelligence in the Diagnosis of Neurodegenerative Disorders (Alzheimer's and Dementia) and in Managing Medication Schedules"
35/100 ✓ Peer-reviewed Digital health tools Damanhour Journal of Intelligent Systems and Informatics
Key finding: The experimental results underscore that the proposed ordinal EfficientNetB0 architecture outperforms other models in fundamental structural tasks, characterized by minimal computational overhead, reduced susceptibility to overfitting, efficient memory utilization, and effective temporal regulation. +1 more finding
Full summary, score breakdown and related studies → Original source
-
2025-06-01
Detection of emergency department patients at risk of dementia through artificial intelligence
41/100 ✓ Peer-reviewed Digital health tools Alzheimer s & Dementia
Key finding: EDDA achieved an area under the receiver-operating characteristic curve (AUROC) of 0.85 in the test set and 0.93 in the validation set. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-01
Impact of APOE4‐related dementia risk in underrepresented groups from the All of Us research program
55/100 ✓ Peer-reviewed Disparities Alzheimer s & Dementia
Key finding: There was a significantly higher risk of developing a dementia diagnosis in Hispanic/Latino and NHB participants than NHW participants and comparably increased dementia hazard ratios in the Hispanic/Latino, NHB, and NHW APOE4 carriers than non-carriers (hazard ratio [HR] [95% confidence interval {CI}] 1.54 [1.25-1.91], 1.25 [1.00-1.57], and 1.55 [1.40-1.72]). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-01
Lifespan exposures to rural–urban conditions and later‐life cognitive function
52/100 ✓ Peer-reviewed Disparities Alzheimer s & Dementia
Key finding: Linear and logistic regression showed that childhood rural residence was associated with lower memory (standardized beta (β) = -1.68, 95% Confidence Interval (CI) [-2.39, -0.97]), executive function (β = -1.20, 95% CI [-1.84, -0.55]), and language fluency (β = -0.86, 95% CI [-1.64, -0.08]). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-01
Ethnic Disparities and Inequalities in Dementia Care: An Extended Literature Review
31/100 ✓ Peer-reviewed Disparities BJPsych Open
Key finding: Across the literature, it is evident that health inequalities currently exist and exacerbate the disparities in the care of BAME dementia patients. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-01
The Post-Traumatic Growth Experience in Family Caregivers of People with Dementia: A Descriptive Qualitative Study
36/100 ✓ Peer-reviewed Caregiving Psychology Research and Behavior Management
Key finding: Four themes were identified, along with eleven sub-themes associated with them: cognitive-behavioral shift (transitioning family roles, recognizing disease characteristics, focusing on health management, and responding positively and effectively); personal strength enhancement (enhancing coping capacity, increased psychological resilience and increased responsibility); improved relationships with others (harmonizing in family relations and benefiting from social interactions); and changes in life perceptions (reshaping of values, and reconstructing the meaning of life). +3 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-01
Competency‐based training boosts dementia knowledge and skills in home care workers
40/100 ✓ Peer-reviewed Caregiving Alzheimer s & Dementia
Key finding: The training significantly improved caregivers' dementia knowledge and self-efficacy but did not reduce caregivers' distress and depression, nor decrease care recipients' emergency room visits and hospitalizations. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-01
Social support interventions for caregivers of older adults with dementia: a scoping review
61/100 ✓ Peer-reviewed Caregiving BMJ Open
Key finding: A total of 31 studies were selected for this review, revealing six distinct categories of social support interventions for caregivers of older adults with dementia. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-01
Sense of Coherence and Caregiver Burden Among Informal Caregivers of People with Dementia in China: The Mediating Role of Coping Strategies
40/100 ✓ Peer-reviewed Caregiving Psychology Research and Behavior Management
Key finding: The caregiver burden was found at a moderate to severe level with the average score of 58.14(12.84). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-01
Blood-brain barrier permeability changes and neuroinflammation in Alzheimer disease progression
35/100 ✓ Peer-reviewed Brain scans and imaging International Journal of Biology Sciences
Key finding: This research investigated how Blood-Brain Barrier (BBB) permeability shifts relate to neuroinflammatory marker profiles across early, moderate, and advanced stages of Alzheimer disease. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-01
LUMEN: Prototype Conversational AI to Streamline Dementia Assessments
31/100 ✓ Peer-reviewed Getting a diagnosis BJPsych Open
Key finding: LUMEN demonstrated strong performance in distinguishing dementia from normal cognition (AUROC=0.89) but moderate subtype differentiation (AUROC=0.66). +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-01
Discrepancies in assessing intellectual disability levels in adults with Down syndrome: Implications for dementia diagnosis
57/100 ✓ Peer-reviewed Getting a diagnosis Alzheimer s & Dementia
Key finding: Inter-rater agreement for ID level classification was 95% within sites but 60% between sites. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-01
Autism, Diagnostics, and Dementia: A Consensus Report From the 2nd International Summit on Intellectual Disabilities and Dementia
46/100 ✓ Peer-reviewed Getting a diagnosis International Journal of Geriatric Psychiatry
Key finding: Diagnostic challenges stem from overlapping symptoms of co-occurring neurodevelopmental and psychiatric conditions, rendering standard dementia tools insufficient. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-01
Lecanemab Binds to Transgenic Mouse Model‐Derived Amyloid‐β Fibril Structures Resembling Alzheimer's Disease Type I, Type II and Arctic Folds
36/100 ✓ Peer-reviewed Treatments Neuropathology and Applied Neurobiology
Key finding: Our results show that lecanemab exhibits high binding affinity to amyloid-β fibril structures that have a flexible N-terminus in common, as is the case for type I, type II and murine type III amyloid-β fibril polymorphs, which resemble or are identical to human structures observed in sporadic and familial cases of Alzheimer's disease, including a case with the Arctic (E22G) mutation. +4 more findings
Full summary, score breakdown and related studies → Original source
-
2025-06-01
“Real‐world” eligibility for anti‐amyloid treatment in a tertiary memory clinic setting
47/100 ✓ Peer-reviewed Treatments Alzheimer s & Dementia
Key finding: Of 1309 new patients, 514 (39% of new patients) had clinical mild cognitive impairment (MCI) or AD. +4 more findings
Full summary, score breakdown and related studies → Original source
Browse the library by subject, with the full score breakdown →